Key Findings:  In a large UK Biobank cohort of over 150,000 individuals, prior cannabis use was associated with a lower incidence of renal cell carcinoma and prostate cancer. A reduced risk of bladder cancer and renal cell carcinoma was observed in females, but not males. No significant association was found between cannabis use and testicular cancer. While Mendelian randomization suggested a potential causal link for reduced renal cell carcinoma risk, findings remain observational and should be interpreted cautiously.
Type of Study:  Meta-analysis
Study Sample Size:  151945
Study Result:  Positive
Research Location(s):  China, France, United Kingdom
Year of Pub:  2022
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Citation:  Huang J, et al. Association between cannabis use with urological cancers: A population-based cohort study and a mendelian randomization study in the UK biobank. Cancer Med. 2023; 12:3468-3476. doi: 10.1002/cam4.5132
Authors:  Huang J, Huang D, Ruan X, Huang J, Xu D, Heavey S, Olivier J, Na R